BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 17760701)

  • 21. Periorbital Discolouration Diagnosis and Treatment: Evidence-Based Review.
    Pissaridou MK; Ghanem A; Lowe N
    J Cosmet Laser Ther; 2020 Nov; 22(6-8):217-225. PubMed ID: 34078228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postinflammatory hyperpigmentation: evolving combination treatment strategies.
    Taylor SC; Burgess CM; Callender VD; Fu J; Rendon MI; Roberts WE; Shalita AR
    Cutis; 2006 Aug; 78(2 Suppl 2):6-19. PubMed ID: 16977792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complications of chronic atopic dermatitis: safely treatable?
    Cho SB; Kim JS; Kim MJ
    J Cosmet Laser Ther; 2009 Sep; 11(3):174-5. PubMed ID: 19337942
    [No Abstract]   [Full Text] [Related]  

  • 24. Imaging of hemoglobin oxygen saturation ratio in the face by spectral camera and its application to evaluate dark circles.
    Kikuchi K; Masuda Y; Hirao T
    Skin Res Technol; 2013 Nov; 19(4):499-507. PubMed ID: 23750856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disorders of hyperpigmentation. Part I. Pathogenesis and clinical features of common pigmentary disorders.
    Wang RF; Ko D; Friedman BJ; Lim HW; Mohammad TF
    J Am Acad Dermatol; 2023 Feb; 88(2):271-288. PubMed ID: 35151757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low risk of postinflammatory hyperpigmentation in skin types 4 and 5 after treatment with fractional CO2 laser device.
    Tan KL; Kurniawati C; Gold MH
    J Drugs Dermatol; 2008 Aug; 7(8):774-7. PubMed ID: 18720695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of microneedling and 10% trichloroacetic acid peels in the management of infraorbital dark circles.
    Kontochristopoulos G; Kouris A; Platsidaki E; Markantoni V; Gerodimou M; Antoniou C
    J Cosmet Laser Ther; 2016 Oct; 18(5):289-92. PubMed ID: 26967571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness, safety, and patient satisfaction of carboxytherapy as an adjunctive treatment for periorbital hyperpigmentation.
    Seirafianpour F; Atefi N; Amin NG; Namazi MR; Behrangi E; Shafiei A; Ghassemi M; Mozafarpoor S; Goodarzi A
    Skin Res Technol; 2024 Mar; 30(3):e13651. PubMed ID: 38483051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing postinflammatory hyperpigmentation in pediatric patients with skin of color.
    Heath CR
    Cutis; 2019 Feb; 103(2):71-73. PubMed ID: 30893390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rejuvenation of the aging chest: a review and our experience.
    Peterson JD; Goldman MP
    Dermatol Surg; 2011 May; 37(5):555-71. PubMed ID: 21463389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Established treatments of skin hypermelanoses.
    Nikolaou V; Stratigos AJ; Katsambas AD
    J Cosmet Dermatol; 2006 Dec; 5(4):303-8. PubMed ID: 17716250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Condition known as "dark rings under the eyes" in the Japanese population is a kind of dermal melanocytosis which can be successfully treated by Q-switched ruby laser.
    Watanabe S; Nakai K; Ohnishi T
    Dermatol Surg; 2006 Jun; 32(6):785-9; discussion 789. PubMed ID: 16792642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decoding infraorbital dark circles with lasers and fillers.
    Kounidas G; Kastora S; Rajpara S
    J Dermatolog Treat; 2022 May; 33(3):1563-1567. PubMed ID: 33272039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of photoaging with a very superficial Er:YAG laser in combination with a broadband light source.
    Berlin AL; Hussain M; Phelps R; Goldberg DJ
    J Drugs Dermatol; 2007 Nov; 6(11):1114-8. PubMed ID: 18038499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukemia cutis presenting as localized cutaneous hyperpigmentation.
    Angulo J; Haro R; González-Guerra E; Fariña MC; Martín L; Requena L
    J Cutan Pathol; 2008 Jul; 35(7):662-5. PubMed ID: 18422694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Atrophie blanche].
    Coget JM; Millien JP
    Phlebologie; 1993; 46(1):3-9. PubMed ID: 8327580
    [No Abstract]   [Full Text] [Related]  

  • 37. Acquired hyperpigmentations.
    Cestari TF; Dantas LP; Boza JC
    An Bras Dermatol; 2014; 89(1):11-25. PubMed ID: 24626644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous idiopathic hyperchromia of the orbital region (CIHOR): a histopathological study.
    Graziosi AC; Quaresma MR; Michalany NS; Ferreira LM
    Aesthetic Plast Surg; 2013 Apr; 37(2):434-8. PubMed ID: 23344465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postinflammatory Hyperpigmentation: Epidemiology, Clinical Presentation, Pathogenesis and Treatment.
    Kaufman BP; Aman T; Alexis AF
    Am J Clin Dermatol; 2018 Aug; 19(4):489-503. PubMed ID: 29222629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ashy dermatosis: clinico-pathological associations in two cases].
    Carboni I; Costanzo A; Campione E; Paternò EJ; Chimenti S
    Clin Ter; 2008; 159(5):321-3. PubMed ID: 18998034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.